#news #biotech Amgen pauses FLT3 bispecific trial, resumes dosing in BCMA study

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Amgen pauses FLT3 bispecific trial, resumes dosing in BCMA study .Amgen pauses FLT3 bispecific trial, resumes dosing in BCMA study
ntaylor
Wed, 08/04/2021 – 07:27

from FierceBiotech: Biotech https://ift.tt/3in6gkL